A False Claims Act lawsuit has been filed by New York Attorney General Eric Schneiderman against Continuum Health Partners in New York City, according to a Washington Examiner report.
Legal & Regulatory Issues
A bill has been introduced that would help coordinate care for children with complex medical conditions who have healthcare coverage through Medicaid.
Daytona, Fla.-based Halifax Hospital Medical Center has filed a motion for summary judgment in an attempt to get the second part of a case against the medical center dismissed before trial begins July 8, according to a Daytona Beach News-Journal…
The U.S. Supreme Court has ruled business owners may refuse to provide their employees with insurance coverage for contraceptives if the owners have religious objections to certain forms of birth control.
The U.S. Court of Appeals for the Sixth Circuit has affirmed the dismissal of almost all of the product liability cases filed against Teva Pharmaceuticals and other companies that sold generic propoxyphene, commonly referred to as Darvon and Davocet.
Advertisement
Cincinnati, Ohio-based Omnicare — the nation's largest provider of pharmaceuticals and pharmacy services to nursing homes — has agreed to pay the government $124.24 million to settle allegations that it violated the False Claims Act and the Anti-Kickback Statute according…
HHS' Office of the Inspector General has issued a special fraud alert warning clinical laboratories and physicians that providing payment to physicians to collect, process and package patients' specimens could violate the Anti-Kickback Statute.
The Obama administration has announced new technology used by CMS to combat healthcare fraud prevented more than $210 million in improper Medicare payments in 2013, according to a Washington Times report.
The U.S. Supreme Court is expected to issue its ruling this week in the case of two companies against the Patient Protection and Affordable Care Act and its contraception coverage mandate. What, exactly, is at stake for the law?
The American Hospital Association — joined by the Pharmaceutical Research and Manufacturers of America and the U.S. Chamber of Commerce — sent a friend-of-the-court brief urging the U.S. Supreme Court to bar civil monetary penalties under the False Claims Act.